At Aware, we believe innovation accelerates through collaboration. By partnering with leaders across defense, healthcare, and industry, we are opening new frontiers in stress-contextual biometric intelligence, AI modeling, drug development, clinical research, and performance diagnostics.
Backed by more than $20 million in funding from the U.S. Navy, hearing aid manufacturers, and consumer tech leaders, Aware developed the FDA-cleared eFit 3D Ear Scanner—a patented, non-contact solution that maps the ear canal in its natural state for superior comfort and sensor performance. Natus licensed our 3D ear scanning technology, branded as Otoscan, which has been adopted by the hearing aid industry and is trusted by audiologists worldwide—proven in clinical use.
This foundation powers custom-fit hearing protection and next-generation in-ear devices designed for deployment across defense, healthcare, industrial, and performance environments. Together with our partners, we are advancing stress-contextual biometric intelligence to transform safety, readiness, and human performance.
Aware pioneered the first in-ear EEG, published in the Journal of Neural Engineering, demonstrating medical-grade brain signal capture from a discreet wearable device. Validated at the Emory Brain Center and funded by Takeda Pharmaceuticals, this breakthrough laid the groundwork for Hearable V2—advancing stress-contextual biometric intelligence to reveal how the brain and body respond under pressure.
With more than ten patents, multiple DoD SBIR awards, and $7.5M in congressional support, Aware is uniquely positioned to help partners create new solutions, datasets, and markets in biometric intelligence—delivering technologies that protect, monitor, and optimize human performance.
